P3 Health Partners raises 2026 adjusted EBITDA guidance range to $90M-$110M as it targets $200M in value creation
We haven't written up this one. Seeking Alpha News has the full story — the link below goes straight to it.
This story
This is one outlet's version. Read the fullest account.